Study of tilrekigim with rHuPH20 in healthy adults
This study tests how a single dose of the study drug tilrekigim (given under the skin together with another drug called rHuPH20) moves through the body of healthy adults. Participation helps researchers understand the drug's effects and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult in good health.
- Your body mass index (BMI) is between 16 and 32.
- You weigh more than 50 kilograms (about 110 pounds).
- You have no significant medical conditions.
- You have never tested positive for HIV, hepatitis B, or hepatitis C.
- You have no history of active, latent, or inadequately treated tuberculosis.
- You have no history of allergic reactions to biologic medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental medicine moves through and leaves the body in healthy volunteers. Researchers will compare different forms of the medicine to understand which works best and is safest.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.